The competitive landscape of the peripheral interventions market includes: prominent companies such as
Biotronik SE & Co. KG
Teleflex Incorporated
Abbott Laboratories
Boston Scientific Corporation
Cook Medical
W. L. Gore & Associates Inc
Cardinal Health Inc
AngioDynamics Inc
Medtronic
B.Braun Melsungen AG
Terumo Corporation
Becton Dickinson and Company (C.R. Bard)
Authors:
Mariam Faizullabhoy , Pratiksha Kamthe
Frequently Asked Questions (FAQ) :
Peripheral interventions industry size was worth USD 8.7 billion in 2022 and is poised to depict over 9% CAGR from 2023-2032 owing to the high prevalence of peripheral artery disease globally.
The catheters product segment is set to grow at 9.3% CAGR from 2023-2032 owing to extensive usage for treatment procedures in hospitalized patients.
North America peripheral interventions industry size is poised to reach over USD 8.1 billion by 2032 attributed to the presence of expanding geriatric patient pool vulnerable to several cardiac disorders in the region
Some of the top peripheral intervention industry players are Biotronik SE & Co. KG, Teleflex Incorporated, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, W. L. Gore & Associates Inc., Cardinal Health Inc., AngioDynamics Inc., Medtronic, and B. Braun Melsungen AG,